Literature DB >> 11701941

Clopidogrel and side effects.

F Reichenberger1, H Wirtz, R Paschke.   

Abstract

Clopidogrel is a recently developed thrombocyte inhibitor with fewer side effects. We report 2 patients with purpura and thrombopenia, respectively, due to clopidogrel therapy. As this compound is widely used in clinical practice, the occurrence of hematological and dermal side effects should be considered. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11701941     DOI： 10.1159/000047386

Source DB:  PubMed          Journal:  Cardiology        ISSN： 0008-6312            Impact factor:   1.869


  2 in total

1.  Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity.

Authors:  Koichi Kokame; Masanori Matsumoto; Kenji Soejima; Hideo Yagi; Hiromichi Ishizashi; Masahisa Funato; Hiroshi Tamai; Mutsuko Konno; Kei Kamide; Yuhei Kawano; Toshiyuki Miyata; Yoshihiro Fujimura
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-14       Impact factor: 11.205

Review 2.  Antiplatelet drug induced isolated profound thrombocytopenia in interventional cardiology: a review based on individual case reports.

Authors:  Thomas Höchtl; Linda Pachinger; Gerhard Unger; Alexander Geppert; Johann Wojta; Job Harenberg; Kurt Huber
Journal:  J Thromb Thrombolysis       Date:  2007-01-20       Impact factor: 5.221
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.